Products | Molecular Health

Applications and solutions

Integrate clinical and molecular data for better decisions

Biomedical data exist in abundance. What is in short supply is the ability to connect information in meaningful ways. Molecular Health software applications and services allow you to leverage our comprehensive repository of clinico-molecular drug and disease data for evidence-based discovery and decision.


Our applications help you understand and predict drug therapy outcomes, clinical trial designs, drug-induced adverse effects and drug-drug interactions. Data has finally become meaningful at the molecular level.

Dataome - the world’s medical data, cleaned and curated
At the center of action is insight. At the center of insight is Dataome. Built and constructed over a decade, our Dataome technology enables the quality-controlled capture, integration and analysis of clinical and molecular knowledge. By connecting real-world patient outcome data to the real-time state of clinical and molecular knowledge, Dataome provides an unparalleled evidence base upon which decision support solutions for the healthcare industry are built.
Read more
Dataome - the world’s medical data, cleaned and curated
Read more

Integrating insight has never been easier

Over the last decade, Dataome has grown to become one of the largest globally available resources of clinico-molecular data and knowledge. From millions of patient lives to hundreds of billions of molecular data points, it provides a single-point of access to the worlds biomedical knowledge through our decision support applications.

Molecular Health Guide (MH Guide) identifies safe and effective therapies for cancer patients by analyzing the cancer’s molecular profile. It matches detected mutations to the world’s knowledge in the field of oncology and helps medical experts to create a patient-specific clinical report with treatment recommendations.


Molecular Health Guide Mendel (MH Mendel) supports human geneticists in diagnosing hereditary diseases and creating diagnostic reports for individual patients. The germline data analysis follows official genetic guidelines and uses ACMG variant classification criteria.


Logo of MH BRCA

Molecular Health Guide BRCA (MH BRCA) supports medical professionals in identifying and reporting clinically significant germline variants following official genetic guidelines. Create individual patient reports based on NGS data from BRCA1/BRCA2 and other genes associated with hereditary breast and ovarian cancer syndrome.

MH Predict Logo

Molecular Health Predict (MH Predict) is an application to predict clinical trials probabilities of success. It enables the improvement of clinical trial success and reduces clinical trial failure while optimizing resource allocation for the biopharma industry and investors and enhancing the overall efficiency of drug development.


Let’s talk about how our technology can work for you

To find out more, you can call our customer service or send us an e-mail. We would be delighted to provide you with more information or answer your questions.